Skip to content
NagentNagent
Log inSign upHire your AI Growth Team
NagentNagent
Log inSign up

Compare AI MLR Assistant Solutions for Pharma Marketing

8 Minutes read
Published:
A neutral comparison of AI tools that help pharmaceutical marketing teams with medical, legal and regulatory review, what each vendor's own site says it does, and the criteria to judge them by.
NA
NagentOct 24, 2026·8 min read
Compare AI MLR Assistant Solutions for Pharma Marketing

To compare AI MLR assistant solutions for pharmaceutical marketing teams, first sort them by where they sit: inside the review system of record, beside it as a pre-check, or upstream as a drafting tool that prepares content for review. Then judge each on the same criteria: what it checks against, how it handles references, who decides, what it records and how it fits your existing workflow. This guide lists real tools, as each vendor's own site describes them, and shows where Nagent fits for pharma teams.

What is an AI MLR assistant?

Medical, legal and regulatory (MLR) review is the step where reviewers approve promotional and medical content before it reaches healthcare professionals or patients. An AI MLR assistant is software that helps with that step without taking the decision away from the reviewers. In practice it does one or more of these jobs:

  • Pre-check. Scans a draft for spelling, brand, guideline and compliance issues before it is submitted, so reviewers see fewer avoidable errors.

  • Reference support. Suggests or links the references behind claims, so reviewers check sources instead of hunting for them.

  • Review support. Answers questions about a document, summarises it or compares it with approved content.

  • Drafting for review. Writes first drafts from approved sources, so content arrives at MLR closer to approvable.

No serious vendor in this list claims its AI approves content. Every one of them keeps the decision with people, and that is the first thing to confirm in any demo.

Which AI MLR assistant solutions are available?

The tools below were each checked on the vendor's own site. The lines describe what each site says, with no ranking and no performance claims. Capabilities change quickly, so confirm current features with each vendor.

  • Solution: Veeva AI for PromoMats, Where it sits: Inside the PromoMats review system, What the official site describes: Quick Check Agent and Content Agent for checks and document review; Falcon MLR announced

  • Solution: Viseven eWizard (eVa), Where it sits: Content authoring platform, before submission, What the official site describes: An MLR agent that flags potential compliance issues and suggests corrections

  • Solution: EY Smart Reviewer, Where it sits: Review approach from a consulting firm, What the official site describes: AI and machine learning applied to repetitive review steps, standalone or integrated

  • Solution: Vodori, Where it sits: Regulated content and review platform, What the official site describes: Content Preflight, an AI pre-check before formal review, with advisory findings

  • Solution: Papercurve, Where it sits: MLR review and content platform, What the official site describes: Generative AI compliance checks and Paige AI for claim references

  • Solution: Nagent, Where it sits: Upstream drafting, before MLR, What the official site describes: Drafts from approved sources with banned claims and mandatory statements; not an MLR system

Veeva AI for PromoMats

Veeva's AI for PromoMats adds agents to Vault PromoMats, the review system many pharma companies already use. In Veeva's December 2025 announcement, Quick Check Agent scans content against editorial, brand, market, channel and compliance guidelines to address issues before MLR review, and Content Agent answers questions about a document, summarises it and analyses its visuals. Veeva also describes custom agents and a newer product, Veeva Falcon MLR, following its acquisition of Copli.

Viseven eWizard and eVa

Viseven's eWizard is a content platform for pharma marketing and medical teams. Its eVa announcement describes an AI agent that builds content layouts and pulls approved snippets from a digital asset management system, and an MLR agent that flags potential compliance issues and suggests corrections before content leaves the platform.

EY Smart Reviewer

EY Smart Reviewer is EY's approach to reviewing life sciences promotional materials. EY says it uses AI and machine learning to handle repetitive review steps so experts can focus on judgement, uses a risk-based framework to prioritise content, and can run standalone or integrate with content management systems.

Vodori

Vodori offers a regulated content platform for life sciences. Its site describes Content Preflight, an AI-powered MLR pre-check that identifies quality and governance issues before formal review. It also states that its AI findings are advisory and recorded, and that the AI never approves, rejects or determines compliance.

Papercurve

Papercurve is a content platform for life sciences that covers MLR review, contracts and sales enablement. Its site describes generative AI that helps catch compliance issues, and Paige AI, which recognises claims and suggests relevant references based on previous usage.

What criteria should you use to compare AI MLR assistants?

Score every option against the same list, and ask to see each answer working on your own content:

  1. What does it check against? Your approved claims, label text, brand guidelines and local codes, or a general model's idea of compliance? Can you see the rules it applied?

  2. How does it handle references? Does it link each claim to its source, suggest references, or leave that to the reviewer?

  3. Who decides? Confirm that findings are advisory and that a named reviewer approves. Be wary of any tool that implies approval is automated.

  4. What is recorded? Every AI finding, every human decision and any override should be kept with who made it and when.

  5. Where does it sit in your workflow? Inside your review system of record, beside it, or upstream in drafting? Tools upstream must hand clean work into the review system, not create a side door around it.

  6. Does it work across markets? Local codes differ. Ask how market and channel rules are configured and who maintains them.

  7. How is your data handled? Where content is processed and stored, whether it is used to train models, and which certifications are held versus in progress.

  8. What happens when the source changes? A label update can make approved content wrong. Ask how the tool finds affected content, and who keeps its rules current.

Should you buy one tool or combine several?

Most pharma teams end up with layers rather than one tool:

  • The review system of record stays where approvals happen and are stored. If you already run one, its native AI features are the natural first test.

  • A pre-check catches avoidable errors before submission. Check whether your review system already includes one before adding another.

  • A drafting layer reduces rework by getting content closer to approvable on the first draft, using only approved sources and your guidelines.

Map your current review cycle first. If most rejections are for missing references, reference support matters most. If most are for prohibited wording, a drafting layer with enforced rules and a pre-check matter more.

Where does Nagent fit among AI MLR assistants?

Nagent is multiplayer AI for growth: people and AI agents in one shared context, delivering the number. It is not an MLR system, it does not approve content and it does not handle adverse event reporting. It sits upstream, preparing drafts so they arrive at your review process in better shape:

  • Drafts from your sources. CREA, the AI Content Chief of Staff, leads a team that researches, drafts, edits and reviews content from your Knowledge Hub, your products and your brand book, then waits for a person. If the Knowledge Hub has nothing on a topic, the draft is written without it rather than inventing detail.

  • Banned claims and mandatory statements. Upload your brand guideline document and it outranks anything read from your website. FOLIO, the long-form publications lead for PDF and DOCX, carries the banned claims and mandatory items from your guidelines into every publication it writes, ahead of tone.

  • Claims checked against proof in paid social creative. HOOK (Beta), the ad creative strategy lead, asks for the claims your brand may make with their proof, and its GATE holds any claim the pack does not support. Overriding a block needs a second person.

  • A person at the gate. Nothing goes live until a person approves it. The team's reviewer reads every post first, and on a draft the team wrote, its rejection holds the post.

  • Security. ISO/IEC 27001:2022 certified by InterCert, with a SOC 2 Type II programme underway. Tenant isolation, role-based access, append-only audit and private VPC are available today. HIPAA is in process, and a BAA is available for healthcare customers.

Nagent's drafts then go into your existing MLR process, and your reviewers keep the decision. The pharma and healthcare page shows how the rest of the growth org works for pharma teams.

How do you run a fair trial of AI MLR assistants?

  1. Pick one content type, such as HCP emails or disease-awareness pages.

  2. Use real, previously reviewed pieces, including some that were rejected, so you know what each tool should catch.

  3. Load the same rules into every tool: approved claims, guidelines and banned phrases.

  4. Measure the same two things for each: issues caught that reviewers also flagged, and issues raised that reviewers would not have.

  5. Keep reviewers in charge throughout, and record every decision as you would in production.

Frequently Asked Questions

What is the difference between an MLR system and an AI MLR assistant?

An MLR system is where content is routed, reviewed, approved and stored as the record. An AI MLR assistant helps inside or around that process, by pre-checking drafts, suggesting references, summarising documents or drafting content for review. The approval stays with reviewers.

Can AI approve pharma promotional content?

No. The vendors in this comparison describe their AI as assisting review, and Vodori's site states its AI never approves, rejects or determines compliance. Medical, legal and regulatory reviewers make the decision.

Which AI MLR assistant integrates with Veeva PromoMats?

Veeva's own AI agents work inside PromoMats. For any other tool, ask the vendor to show the integration with your PromoMats setup, including how findings and decisions are recorded.

Is Nagent an MLR review tool?

No. Nagent prepares drafts for MLR review: its teams write from your approved sources and guidelines, and a person approves before anything goes live. Your MLR system and reviewers stay in charge of approval.

Compare on your own content

The right AI MLR assistant is the one that catches what your reviewers catch, records every decision and fits the review system you already trust. If you want drafts that reach review closer to approvable, see how Nagent works for pharma teams.

Book a demo to see Nagent draft for your MLR process.

AI agents for Pharma & Healthcare

Continue learning

Related agents

Agents that match this read.

Browse all 200+ agents
Select Category